Serum Institute's Adar Poonawalla urges US to lift raw material export ban to ramp up vaccine production

SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by AstraZeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news